Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Clinical trial NCT00121303 · COMPLETED

Trial details

NCT number: NCT00121303
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 2005-01-01
Primary completion: 2009-01-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.